Oxacillin Sodium

苯唑西林钠

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameOxacillin Sodium
Drug Alias Nameoxacillinum新青霉素Ⅱoxacilline苯唑青霉素钠oxacilina +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell wall inhibitors
TargetsNot applicable
Therapy Area/IndicationsStaphylococcal Infections
Global Approved IndicationsStaphylococcal Infections
Approved Indications in ChinaStaphylococcal Infections
Original Approved Country/TerritoryMainland China
Original Approved Date1981/01/01
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesBaxter HlthcareSichuan Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsStaphylococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01CF04
Related LinksWikipediaDrugBankKEGG